Standout Papers

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin 2014 2026 2018 2022 391
  1. Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin (2014)
    Stefan Zeuzem, Ira M. Jacobson et al. New England Journal of Medicine

Immediate Impact

80 standout
Sub-graph 1 of 20

Citing Papers

Metabolic reprogramming in liver fibrosis
2024 Standout
Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment
2023 Standout
2 intermediate papers

Works of Peter Varunok being referenced

Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
2014 Standout

Author Peers

Author Last Decade Papers Cites
Peter Varunok 531 478 147 4 550
Mostafa Habib 454 371 96 7 581
Wulf O. Boecher 540 484 102 11 576
Stephen D. Shafran 421 440 79 15 528
John A. Routenberg 363 278 207 8 480
Julia O’Brien 392 389 72 10 490
C Martín-Vega 501 486 35 13 636
Jody Mooney 398 325 96 5 582
Sousuke Terazawa 533 524 74 5 620
G. Carosi 474 438 77 9 520
Katsutaro Hirota 378 434 59 13 568

All Works

Loading papers...

Rankless by CCL
2026